Hazard map articles should describe the development of a volcanic hazard map or set of volcanic hazard maps. Where appropriate, articles should also describe the dissemination, socialisation and use of the hazard map(s). We also welcome articles that discuss volcanic risk maps.
This article type is open to contributions describing any volcanic hazard map, including old maps, new maps, and maps that are still being prepared. The map(s) may be officially recognised by government agencies or other organizations, or it may be awaiting official or local uptake, or have been developed for purely scientific purposes.
The article should include a reproduction of the hazard map(s), or example(s) of a hazard map from a map suite. Figure captions should include any relevant copyright permissions, if maps have been published elsewhere. It is the authors' responsibility to ensure that their contribution does not infringe any existing copyright or any other third party rights as stated under the terms of the licence agreement. There is an expectation that the paper correctly refers to hazard and/or risk (https://www.unisdr.org/we/inform/terminology) to support clear mapping and management of hazard and risk by not confusing these inter-related concepts.
The Journal of Applied Volcanology strongly encourages that authors make all datasets on which the hazard map or set of maps are based available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate), or presented in the main manuscript or additional supporting files whenever possible. Please see Springer Nature’s information on recommended repositories.
There is no word limit for the abstract or article. Please be concise and consider the article type you have chosen for your manuscript.
Preparing your manuscript
The title page should:
- present a title that includes the name of the volcano(es) or volcanic region covered by the hazard map or set of maps
- list the full names, institutional addresses and email addresses for all authors
- if a collaboration group or institution should be listed as an author, please list the name of the group or institution as an author and include the names of any individual members of the group or institution in the “Acknowledgements” section in accordance with the instructions below
- provide contact details for the corresponding author
The abstract should briefly summarize the whole article including the context for map development, hazard assessment style, map-making approach and any conclusions and recommendations. Please minimize the use of abbreviations and do not cite references in the abstract. See the criteria section for this article type (located at the top of this page) for information on abstract and article word limits.
Three to ten keywords representing the main content of the article.
The introduction should provide the context for the map or map set.
The main body of the article can be divided up into headings as appropriate. All articles should include:
- Who: An explanation of all individuals and agencies who were involved in preparing the map(s)
- Why: An explanation of the aim(s)/purpose(s) of the map(s), including any desired messages
- How: An explanation of the hazard (or risk) analysis, and a description of the method and rationale for the design of the map(s), including depiction of zones etc
- Status: A statement about whether the map(s) was produced or formally adopted by the institution with the responsibility for assessing volcano hazards in the pertinent country(ies)
In addition to the key content above, the article could include any or all of the following:
- Geological and geographical setting
- Eruptive history
- Past work on volcanic hazard assessment or hazard maps at the volcano(es)
- Approach/method for integrating volcanic hazard data to make the map(s)
- Approach/method for designing and producing the map(s)
- Cartographic elements
- Novel or innovative aspects
- Stakeholder engagement
- Piloting, testing, evaluating the map(s)
- Actual or planned dissemination and/or socialisation of the map(s)
- Use/uptake of the maps
- Challenges encountered and lessons learned
- Recommendations for researchers or other map-makers
Some of the above sections may naturally fall within a Discussion. This section should discuss the implications of the map(s) or map-making process in the context of existing research. It should also highlight limitations of the hazard map(s) and lessons learned, and recommend steps that can be taken to overcome such limitations when developing comparable maps. Can also be combined with the Conclusion section.
This should state clearly the main conclusions and provide an explanation of the importance and relevance of the contribution to the research field and/or other map makers.
All manuscripts must contain the following sections under the heading 'Declarations':
- Availability of data and material
- Competing interests
- Authors' contributions
- Authors' information (optional)
Please see below for details on the information to be included in these sections.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
Availability of data and materials
For all journals, BioMed Central strongly encourages all datasets on which the conclusions of the manuscript rely to be either deposited in publicly available repositories (where available and appropriate) or presented in the main paper or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible. Please see the list of recommended repositories in our editorial policies.
For some journals, deposition of the data on which the conclusions of the manuscript rely is an absolute requirement. Please check the Criteria section for this article type (located at the top of this page) for journal specific policies.
For all journals, authors must include an “Availability of data and materials” section in their article detailing where the data supporting their findings can be found. If you do not wish to share your data, please state that data will not be shared, and state the reason.
For instructions on how to cite your data and format this section see preparation/style and formatting.
All financial and non-financial competing interests must be declared in this section. See our editorial policies for a full explanation of competing interests. If you are unsure whether you or any of your co-authors have a competing interest please contact the editorial office.
All sources of funding for the research reported should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.
The individual contributions of authors to the manuscript should be specified in this section.
Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.
See our editorial policies for a full explanation of acknowledgements and authorship criteria.
Group authorship: if you would like the names of the individual members of a collaboration Group to be searchable through their individual PubMed records (where applicable), please ensure that the title of the collaboration Group is included on the title page and in the submission system and also include collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country information for each author if you wish, but this should be consistent across all authors.
You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.
Endnotes should be designated within the text using a superscript lowercase letter and all notes (along with their corresponding letter) should be included in the Endnotes section. Please format this section in a paragraph rather than a list.
Examples of the Basic Springer reference style are shown below.
See our editorial policies for author guidance on good citation practice.
Web links and URLs: All web links and URLs, including links to the authors' own websites, should be given a reference number and included in the reference list rather than within the text of the manuscript. They should be provided in full, including both the title of the site and the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology Database. http://tumor.informatics.jax.org/mtbwi/index.do. Accessed 20 May 2013. If an author or group of authors can clearly be associated with a web link, such as for weblogs, then they should be included in the reference.
Example reference style:
Article within a journal
Smith J, Jones M Jr, Houghton L (1999) Future of health insurance. N Engl J Med 965:325-329.
Article by DOI (with page numbers)
Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med 78:74-80. doi:10.1007/s001090000086.
Article by DOI (before issue publication and with page numbers)
Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med. doi:10.1007/s001090000086.
Article in electronic journal by DOI (no paginated version)
Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. Dig J Mol Med. doi:10.1007/s801090000086.
Journal issue with issue editor
Smith J (ed) (1998) Rodent genes. Mod Genomics J 14(6):126-233.
Journal issue with no issue editor
Mod Genomics J (1998) Rodent genes. Mod Genomics J 14(6):126-233.
Book chapter, or an article within a book
Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York.
Complete book, authored
South J, Blass B (2001) The future of modern genomics. Blackwell, London.
Complete book, edited
Smith J, Brown B (eds) (2001) The demise of modern genomics. Blackwell, London.
Complete book, also showing a translated edition [Either edition may be listed first.]
Adorno TW (1966) Negative Dialektik. Suhrkamp, Frankfurt. English edition: Adorno TW (1973) Negative Dialectics (trans: Ashton EB). Routledge, London.
Chapter in a book in a series without volume titles
Schmidt H (1989) Testing results. In: Hutzinger O (ed) Handbook of environmental chemistry, vol 2E. Springer, Heidelberg, p 111.
Chapter in a book in a series with volume titles
Smith SE (1976) Neuromuscular blocking drugs in man. In: Zaimis E (ed) Neuromuscular junction. Handbook of experimental pharmacology, vol 42. Springer, Heidelberg, pp 593-660.
OnlineFirst chapter in a series (without a volume designation but with a DOI)
Saito, Yukio, and Hyuga, Hiroyuki. (2007) Rate equation approaches to amplification of enantiomeric excess and chiral symmetry breaking. Topics in Current Chemistry. doi:10.1007/128_2006_108.
Proceedings as a book (in a series and subseries)
Zowghi D (1996) A framework for reasoning about requirements in evolution. In: Foo N, Goebel R (eds) PRICAI'96: topics in artificial intelligence. 4th Pacific Rim conference on artificial intelligence, Cairns, August 1996. Lecture notes in computer science (Lecture notes in artificial intelligence), vol 1114. Springer, Heidelberg, p 157.
Article within conference proceedings with an editor (without a publisher)
Aaron M (1999) The future of genomics. In: Williams H (ed) Proceedings of the genomic researchers, Boston, 1999.
Article within conference proceedings without an editor (without a publisher)
Chung S-T, Morris RL (1978) Isolation and characterization of plasmid deoxyribonucleic acid from Streptomyces fradiae. In: Abstracts of the 3rd international symposium on the genetics of industrial microorganisms, University of Wisconsin, Madison, 4-9 June 1978.
Article presented at a conference
Chung S-T, Morris RL (1978) Isolation and characterization of plasmid deoxyribonucleic acid from Streptomyces fradiae. Paper presented at the 3rd international symposium on the genetics of industrial microorganisms, University of Wisconsin, Madison, 4-9 June 1978.
Norman LO (1998) Lightning rods. US Patent 4,379,752, 9 Sept 1998.
Trent JW (1975) Experimental acute renal failure. Dissertation, University of California.
Book with institutional author
International Anatomical Nomenclature Committee (1966) Nomina anatomica. Excerpta Medica, Amsterdam.
In press article
Major M (2007) Recent developments. In: Jones W (ed) Surgery today. Springer, Dordrecht (in press).
Doe J (1999) Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available via DIALOG. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.
Healthwise Knowledgebase (1998) US Pharmacopeia, Rockville. http://www.healthwise.org. Accessed 21 Sept 1998.
Supplementary material/private homepage
Doe J (2000) Title of supplementary material. http://www.privatehomepage.com. Accessed 22 Feb 2000.
Doe J (1999) Title of preprint. http://www.uni-heidelberg.de/mydata.html. Accessed 25 Dec 1999.
Doe J (1999) Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt. Accessed 12 Nov 1999.
ISSN International Centre (2006) The ISSN register. http://www.issn.org. Accessed 20 Feb 2007.
Annual Journal Metrics
93 days to first decision for reviewed manuscripts only
93 days to first decision for all manuscripts
221 days from submission to acceptance
25 days from acceptance to publication
168 Altmetric mentions
- ISSN: 2191-5040 (electronic)